Genentech's Alzheimer's antibody trial to study disease prevention | Pharmaceutics_R&D | Scoop.it

The first clinical trial of a drug's ability to forestall Alzheimer's disease in cognitively healthy individuals is preparing to launch. Genentech of S. San Francisco, California, the Banner Alzheimer's Institute in Phoenix,…- by Ken GarberNature Biotechnology 30, 731–732, 7 August 2012